Caremark Rx — Proxy Contest (February 2007)
5 slides from Caremark Rx's proxy contest presentation, Feb 12, 2007
Slide 1: Important Information
Important Information Express Scripts has filed a proxy statement in connection with Caremark's special meeting of stockholders at which the Caremark stockholders will consider the CVS Merger Agreement and matters in connection therewith. Express Scripts stockholders are strongly advised to read tha
Slide 2: Transaction Update
Launched $26 billion Exchange Offer to acquire CMX, which will deliver superior value to stockholders Secured financing Nominated slate of directors Filed proxy in opposition to proposed CVS/CMX merger Re-filed HSR & continue to work with FTC Met with many investors and analysts, including Instituti
Slide 3: Why the CVS Deal Is Inferior and the Express Scripts Offer Is Superior
Why the CVS Deal Is Inferior and the Express Scripts Offer Is Superior Destructive: History teaches that the market punishes deals like this Dilutive: CMX stockholders move from high-growth industry to slower-growing retail pharmacy industry Doesn't Add Up: Stated strategy for merger and resulting s
Slide 4: Setting the record straight
Q1 04 Q2 04 Q3 04 Q4 04 Q1 05 Q2 05 Q3 05 Q4 05 Q1 06 Q2 06 Q3 06 Caremark 0.32 0.3 0.38 0.45 0.43 0.47 0.51 0.55 0.51 0.57 0.65 Medco 0.48 0.56 0.53 0.58 0.57 0.58 0.53 0.66 0.56 0.65 0.69 MHS is the PBM for FEP CMX is the PBM for FEP Large clients may impact revenue, but often have little impact o
Slide 5: Important Information
IMPORTANT INFORMATION Express Scripts has filed a proxy statement in connection with Caremark's special meeting of stockholders at which the Caremark stockholders will consider the CVS Merger Agreement and matters in connection therewith. Express Scripts stockholders are strongly advised to read tha